UM

Browse/Search Results:  1-1 of 1 Help

Selected(0)Clear Items/Page:    Sort:
Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy Journal article
Lei, Josh Haipeng, Lee, Mi Hye, Miao, Kai, Huang, Zebin, Yao, Zhicheng, Zhang, Aiping, Xu, Jun, Zhao, Ming, Huang, Zenan, Zhang, Xin, Chen, Si, Jiaying, N. G., Feng, Yuzhao, Xing, Fuqiang, Chen, Ping, Sun, Heng, Chen, Qiang, Xiang, Tingxiu, Chen, Lin, Xu, Xiaoling, Deng, Chu Xia. Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy[J]. Advanced Science, 2021, 8(21), 2100974.
Authors:  Lei, Josh Haipeng;  Lee, Mi Hye;  Miao, Kai;  Huang, Zebin;  Yao, Zhicheng; et al.
Favorite | TC[WOS]:23 TC[Scopus]:17  IF:14.3/16.3 | Submit date:2021/11/30
Brca1  Breast Cancer  Fgfr2 Inhibitor  Fgfr2-s252w  Tumor Slice Culture